Device Trial Radar · NCT03093935
StimRouter™ for Pain Management in Post-stroke Shoulder Pain
Last checked: Nov 20, 2026Latest source record: Jan 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
6
Actual
Start
Jul 1, 2018
Primary completion
Nov 20, 2020
Study completion Nov 20, 2020
Sponsor
- Lead sponsor
- Bioness IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 28, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study through 6 months of follow-up. Various measures will be used to assess patient response to use of the device.
Conditions
- Chronic Pain
- Hemiplegic Shoulder Pain
Interventions
StimRouter Neuromodulation SystemDevice
The StimRouter Neuromodulation System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as an adjunct to other modes of therapy (e.g., medications). The StimRouter is not intended to treat pain in the craniofacial region.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Brief Pain Inventory (BPI) ChangeTime frame: Change from Baseline at Month 3
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Miami
Miami, Florida
University of Utah
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.